Global Differentiated Thyroid Cancer Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: GE0CD72CAF4DEN
QYResearch

Abstracts

This report focuses on the global Differentiated Thyroid Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Differentiated Thyroid Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Mylan pharmaceuticals
• Baxter
• Alara Pharmaceutical
• Abbott laboratories
• Bristol Myers
• Teva
• Jerome Stevens
• ...

Market segment by Type, the product can be split into

• Radioiodine Ablation
• Thyroid Stimulating Hormone (THS) Suppression
• Chemotherapy
• Targeted Multikinase Therapy
• Others

Market segment by Application, split into

• Hospitals
• Oncology Canters
• Hospital Pharmacies
• Retail Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Differentiated Thyroid Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Differentiated Thyroid Cancer Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Differentiated Thyroid Cancer Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Differentiated Thyroid Cancer Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Differentiated Thyroid Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Radioiodine Ablation
  1.4.3 Thyroid Stimulating Hormone (THS) Suppression
  1.4.4 Chemotherapy
  1.4.5 Targeted Multikinase Therapy
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Differentiated Thyroid Cancer Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Oncology Canters
  1.5.4 Hospital Pharmacies
  1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Differentiated Thyroid Cancer Therapeutics Market Perspective (2015-2026)
2.2 Differentiated Thyroid Cancer Therapeutics Growth Trends by Regions
  2.2.1 Differentiated Thyroid Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Differentiated Thyroid Cancer Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Differentiated Thyroid Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Differentiated Thyroid Cancer Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Differentiated Thyroid Cancer Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Differentiated Thyroid Cancer Therapeutics Players by Market Size
  3.1.1 Global Top Differentiated Thyroid Cancer Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Differentiated Thyroid Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Differentiated Thyroid Cancer Therapeutics Market Concentration Ratio
  3.2.1 Global Differentiated Thyroid Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Differentiated Thyroid Cancer Therapeutics Revenue in 2019
3.3 Differentiated Thyroid Cancer Therapeutics Key Players Head office and Area Served
3.4 Key Players Differentiated Thyroid Cancer Therapeutics Product Solution and Service
3.5 Date of Enter into Differentiated Thyroid Cancer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Differentiated Thyroid Cancer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Differentiated Thyroid Cancer Therapeutics Forecasted Market Size by Type (2021-2026)

5 DIFFERENTIATED THYROID CANCER THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)
5.2 Global Differentiated Thyroid Cancer Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
6.2 Differentiated Thyroid Cancer Therapeutics Key Players in North America (2019-2020)
6.3 North America Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
6.4 North America Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
7.2 Differentiated Thyroid Cancer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
8.2 Differentiated Thyroid Cancer Therapeutics Key Players in China (2019-2020)
8.3 China Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
8.4 China Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
9.2 Differentiated Thyroid Cancer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
10.2 Differentiated Thyroid Cancer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
11.2 Differentiated Thyroid Cancer Therapeutics Key Players in India (2019-2020)
11.3 India Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
11.4 India Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Differentiated Thyroid Cancer Therapeutics Market Size (2015-2020)
12.2 Differentiated Thyroid Cancer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Mylan pharmaceuticals
  13.1.1 Mylan pharmaceuticals Company Details
  13.1.2 Mylan pharmaceuticals Business Overview and Its Total Revenue
  13.1.3 Mylan pharmaceuticals Differentiated Thyroid Cancer Therapeutics Introduction
  13.1.4 Mylan pharmaceuticals Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020))
  13.1.5 Mylan pharmaceuticals Recent Development
13.2 Baxter
  13.2.1 Baxter Company Details
  13.2.2 Baxter Business Overview and Its Total Revenue
  13.2.3 Baxter Differentiated Thyroid Cancer Therapeutics Introduction
  13.2.4 Baxter Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
  13.2.5 Baxter Recent Development
13.3 Alara Pharmaceutical
  13.3.1 Alara Pharmaceutical Company Details
  13.3.2 Alara Pharmaceutical Business Overview and Its Total Revenue
  13.3.3 Alara Pharmaceutical Differentiated Thyroid Cancer Therapeutics Introduction
  13.3.4 Alara Pharmaceutical Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
  13.3.5 Alara Pharmaceutical Recent Development
13.4 Abbott laboratories
  13.4.1 Abbott laboratories Company Details
  13.4.2 Abbott laboratories Business Overview and Its Total Revenue
  13.4.3 Abbott laboratories Differentiated Thyroid Cancer Therapeutics Introduction
  13.4.4 Abbott laboratories Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
  13.4.5 Abbott laboratories Recent Development
13.5 Bristol Myers
  13.5.1 Bristol Myers Company Details
  13.5.2 Bristol Myers Business Overview and Its Total Revenue
  13.5.3 Bristol Myers Differentiated Thyroid Cancer Therapeutics Introduction
  13.5.4 Bristol Myers Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
  13.5.5 Bristol Myers Recent Development
13.6 Teva
  13.6.1 Teva Company Details
  13.6.2 Teva Business Overview and Its Total Revenue
  13.6.3 Teva Differentiated Thyroid Cancer Therapeutics Introduction
  13.6.4 Teva Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
  13.6.5 Teva Recent Development
13.7 Jerome Stevens
  13.7.1 Jerome Stevens Company Details
  13.7.2 Jerome Stevens Business Overview and Its Total Revenue
  13.7.3 Jerome Stevens Differentiated Thyroid Cancer Therapeutics Introduction
  13.7.4 Jerome Stevens Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
  13.7.5 Jerome Stevens Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Differentiated Thyroid Cancer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Differentiated Thyroid Cancer Therapeutics Revenue
Table 3. Ranking of Global Top Differentiated Thyroid Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Differentiated Thyroid Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Radioiodine Ablation
Table 6. Key Players of Thyroid Stimulating Hormone (THS) Suppression
Table 7. Key Players of Chemotherapy
Table 8. Key Players of Targeted Multikinase Therapy
Table 9. Key Players of Others
Table 10. Global Differentiated Thyroid Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Differentiated Thyroid Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Differentiated Thyroid Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Differentiated Thyroid Cancer Therapeutics Market Share by Regions (2015-2020)
Table 14. Global Differentiated Thyroid Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Differentiated Thyroid Cancer Therapeutics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Differentiated Thyroid Cancer Therapeutics Market Growth Strategy
Table 20. Main Points Interviewed from Key Differentiated Thyroid Cancer Therapeutics Players
Table 21. Global Differentiated Thyroid Cancer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Differentiated Thyroid Cancer Therapeutics Market Share by Players (2015-2020)
Table 23. Global Top Differentiated Thyroid Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Differentiated Thyroid Cancer Therapeutics as of 2019)
Table 24. Global Differentiated Thyroid Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Differentiated Thyroid Cancer Therapeutics Product Solution and Service
Table 27. Date of Enter into Differentiated Thyroid Cancer Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Differentiated Thyroid Cancer Therapeutics Market Size Share by Type (2015-2020)
Table 31. Global Differentiated Thyroid Cancer Therapeutics Revenue Market Share by Type (2021-2026)
Table 32. Global Differentiated Thyroid Cancer Therapeutics Market Size Share by Application (2015-2020)
Table 33. Global Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Differentiated Thyroid Cancer Therapeutics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 37. North America Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 39. North America Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 43. Europe Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 45. Europe Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 47. China Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 49. China Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 50. China Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 51. China Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 52. China Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 55. Japan Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 57. Japan Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 61. Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 63. Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 65. India Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 67. India Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 68. India Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 69. India Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 70. India Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Differentiated Thyroid Cancer Therapeutics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Differentiated Thyroid Cancer Therapeutics Market Share (2019-2020)
Table 73. Central & South America Differentiated Thyroid Cancer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Differentiated Thyroid Cancer Therapeutics Market Share by Type (2015-2020)
Table 75. Central & South America Differentiated Thyroid Cancer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Differentiated Thyroid Cancer Therapeutics Market Share by Application (2015-2020)
Table 77. Mylan pharmaceuticals Company Details
Table 78. Mylan pharmaceuticals Business Overview
Table 79. Mylan pharmaceuticals Product
Table 80. Mylan pharmaceuticals Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 81. Mylan pharmaceuticals Recent Development
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Product
Table 85. Baxter Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 86. Baxter Recent Development
Table 87. Alara Pharmaceutical Company Details
Table 88. Alara Pharmaceutical Business Overview
Table 89. Alara Pharmaceutical Product
Table 90. Alara Pharmaceutical Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 91. Alara Pharmaceutical Recent Development
Table 92. Abbott laboratories Company Details
Table 93. Abbott laboratories Business Overview
Table 94. Abbott laboratories Product
Table 95. Abbott laboratories Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 96. Abbott laboratories Recent Development
Table 97. Bristol Myers Company Details
Table 98. Bristol Myers Business Overview
Table 99. Bristol Myers Product
Table 100. Bristol Myers Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 101. Bristol Myers Recent Development
Table 102. Teva Company Details
Table 103. Teva Business Overview
Table 104. Teva Product
Table 105. Teva Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 106. Teva Recent Development
Table 107. Jerome Stevens Company Details
Table 108. Jerome Stevens Business Overview
Table 109. Jerome Stevens Product
Table 110. Jerome Stevens Revenue in Differentiated Thyroid Cancer Therapeutics Business (2015-2020) (Million US$)
Table 111. Jerome Stevens Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Differentiated Thyroid Cancer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Radioiodine Ablation Features
Figure 3. Thyroid Stimulating Hormone (THS) Suppression Features
Figure 4. Chemotherapy Features
Figure 5. Targeted Multikinase Therapy Features
Figure 6. Others Features
Figure 7. Global Differentiated Thyroid Cancer Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Oncology Canters Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Differentiated Thyroid Cancer Therapeutics Report Years Considered
Figure 13. Global Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Differentiated Thyroid Cancer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Differentiated Thyroid Cancer Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Differentiated Thyroid Cancer Therapeutics Market Share by Players in 2019
Figure 18. Global Top Differentiated Thyroid Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Differentiated Thyroid Cancer Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Differentiated Thyroid Cancer Therapeutics Revenue in 2019
Figure 20. North America Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Differentiated Thyroid Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Mylan pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Mylan pharmaceuticals Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 29. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Baxter Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 31. Alara Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Alara Pharmaceutical Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 33. Abbott laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Abbott laboratories Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 35. Bristol Myers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bristol Myers Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 37. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Teva Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 39. Jerome Stevens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Jerome Stevens Revenue Growth Rate in Differentiated Thyroid Cancer Therapeutics Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed